Oncolytic herpes simplex virus and its advances in cancer therapy
Jia Wei-guo
Abstract
Jia Wei-guo
Abstract
Oncolytic virotherapy represents an emerging modality with tremendous promise for cancer treatment. Among various oncolytic virues,oncolytic herpes simplex virus is one of the most widely explored agents and shows significant anti tumor activity.In this review,we mainly discuss the advantages of oncolytic HSV,the principles of HSV genetic manipulation,the strategies of oncolytic HSV development and targeting,the ad- vances and challenges of oncolytic HSV in cancer therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Oncolytic virotherapy represents an emerging modality with tremendous promise for cancer treatment. Among various oncolytic virues,oncolytic herpes simplex virus is one of the most widely explored agents and shows significant anti tumor activity.In this review,we mainly discuss the advantages of oncolytic HSV,the principles of HSV genetic manipulation,the strategies of oncolytic HSV development and targeting,the ad- vances and challenges of oncolytic HSV in cancer therapy.
Key concepts: Oncolytic virus, Herpes simplex virus, Virotherapy, Cancer therapy, Virology, Virus, Cancer, Medicine